Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_assertion type Assertion NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_head.
- NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_assertion wasGeneratedBy ECO_0000203 NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_provenance.
- NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_assertion wasDerivedFrom befree-2016 NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_provenance.
- NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_assertion SIO_000772 24195468 NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_provenance.
- NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_assertion evidence source_evidence_literature NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_provenance.
- NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_assertion description "[Serum sialyl Lewis X antigen level increased when the adenocarcinoma component was dominant, whereas plasma pro-gastrin-releasing peptide level increased when the small-cell lung cancer component became dominant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1125332.RAg17Cwkkq0XY-ywFXoQWZO40Hnj5oe1Ug__JUzvqkOOE130_provenance.